Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_assertion type Assertion NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_head.
- NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_assertion description "[The results suggest that these markers should be considered in the design and interpretation of future trials with selective BRAF inhibitors in advanced melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_provenance.
- NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_assertion evidence source_evidence_literature NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_provenance.
- NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_assertion SIO_000772 23833299 NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_provenance.
- NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_assertion wasDerivedFrom befree-2016 NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_provenance.
- NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_assertion wasGeneratedBy ECO_0000203 NP1092088.RAbgpyBZY6OwftKKtpXmUErEjsCTP5xQ4wBlKN5HeQkkk130_provenance.